Search Results 931-940 of 17861 for Assay

1. Allergy skin tests - Mayo Clinic

   Considering skin testing for your allergies? Learn about the risks, results and what to expect during testing.

2. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Serum free light chain assay: involved free light chain level ≥ 10 mg/dL (≥ 100 mg/L), provided that the serum free light chain ratio is abnormal.

3. Dementia Clinical Trials - Mayo Clinic Research

   Blinded Comparison of Different Alpha-Synuclein Seeding Assays as ... assay measures of aSyn, relative to normal control subjects. Specific Aim 2.

4. A Registry to Form a Long-Term Therapeutic and Research Network for Hepatitis C - Mayo Clinic

   Studies comparing HCV RNA assays are not considered exclusionary. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

5. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Known PD-L1 tumor status as determined by an IHC assay performed by a central laboratory on previously obtained archival tumor tissue or tissue obtained from a ...

6. Uncovering Signaling Pathways That Regulate Invasion and Metastasis of Cancer Cells - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

   Current research in the laboratory focuses on developing assays that can be clinically used to determine PKD1 and PKD3 expression in patient samples. The ...

7. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   If subject BRAF mutation status is unknown, before randomization the subject must have BRAF testing performed using an approved assay method;; Patients with ...

8. Study of bb21217 in Multiple Myeloma - Mayo Clinic

   Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. For Part A (Dose ...

9. Pneumonia Clinical Trials

   The study also aims to develop a biomarker assay to detect circulating antigen in patients infected with Coccidioides. A Study to Assess Pulsed Inhaled ...

10. I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY) - Mayo Clinic

    Any tumor ER/PgR status, any HER-2/neu status as measured by local hospital pathology laboratory and meets any tumor assay profile described in protocol section ...